Amplify Treatments, Testing And Advancements ETF BNTX Holdings History
Amplify Treatments, Testing and Advancements ETF's BioNTech SE Holding Summary
As of 2024-06-30, Amplify Treatments, Testing and Advancements ETF held 5,765.00 shares of BioNTech SE(BNTX), totaling $463,280.00. This investment constitutes 5.07% of their stock portfolio, and Amplify Treatments, Testing and Advancements ETF now holds 0% of the outstanding BioNTech SE(BNTX) stock.
The initial trade took place in 2024Q1. In addition, there have been 1 sales at an average price of $91.41 for 1,614.00 shares. Based on historical transaction data and BNTX's current price of $114.57, Amplify Treatments, Testing and Advancements ETF's estimated gain on his BNTX holdings is $100,459.48, reflecting a 14.20% gain to date.
Amplify Treatments, Testing and Advancements ETF BNTX ($114.57) Holding Chart
Amplify Treatments, Testing and Advancements ETF BNTX ($114.57) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
